Incapta Pharma

Incapta Pharma is a specialty pharmaceutical company and a subsidiary of Incapta, Inc. (OTC: INCP). The company focuses on the development and commercialization of proprietary drug formulations, with a primary emphasis on non-opioid pain management solutions. Its lead candidate, Incapta-1, is being developed as a safer alternative to traditional opioid analgesics for various pain indications. Incapta Pharma's business model involves identifying and acquiring niche pharmaceutical assets that address significant unmet medical needs. The company leverages its position within the public markets to support the clinical advancement of its pipeline and expand its healthcare portfolio.